ReP USP - Resultado da busca

Final results of the fibromet trial: an open label phase II study to evaluate metformin effects on bone marrow fibrosis and disease progression in primary myelofibrosis patients (2021)

Campos, Paula de Melo; Pagnano, Katia B.; Mancuso, Rubia Isler; Della Via, Fernanda Isabel; Tinoco, Ângela Condotta; Mendonça, Guilherme Rossi Assis ; Freitas, Leandro Luiz Lopes; Traina, Fabiola ; Saad, Sara T. Olalla

Source: Blood. Conference titles: ASH Annual Meeting. Unidade: FMRP

Subjects: DOENÇAS INFECCIOSAS, FEBRE, DENGUE, ESTUDOS SOROEPIDEMIOLÓGICOS, RESÍDUOS SÓLIDOS

A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

ABNT
CAMPOS, Paula de Melo et al. Final results of the fibromet trial: an open label phase II study to evaluate metformin effects on bone marrow fibrosis and disease progression in primary myelofibrosis patients. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood-2021-151077. Acesso em: 30 abr. 2026. , 2021
APA
Campos, P. de M., Pagnano, K. B., Mancuso, R. I., Della Via, F. I., Tinoco, Â. C., Mendonça, G. R. A., et al. (2021). Final results of the fibromet trial: an open label phase II study to evaluate metformin effects on bone marrow fibrosis and disease progression in primary myelofibrosis patients. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1182/blood-2021-151077
NLM
Campos P de M, Pagnano KB, Mancuso RI, Della Via FI, Tinoco ÂC, Mendonça GRA, Freitas LLL, Traina F, Saad STO. Final results of the fibromet trial: an open label phase II study to evaluate metformin effects on bone marrow fibrosis and disease progression in primary myelofibrosis patients [Internet]. Blood. 2021 ; 138 2584-2585.[citado 2026 abr. 30 ] Available from: https://doi.org/10.1182/blood-2021-151077
Vancouver
Campos P de M, Pagnano KB, Mancuso RI, Della Via FI, Tinoco ÂC, Mendonça GRA, Freitas LLL, Traina F, Saad STO. Final results of the fibromet trial: an open label phase II study to evaluate metformin effects on bone marrow fibrosis and disease progression in primary myelofibrosis patients [Internet]. Blood. 2021 ; 138 2584-2585.[citado 2026 abr. 30 ] Available from: https://doi.org/10.1182/blood-2021-151077

Reactive oxygen species production triggers green tea-induced anti-leukaemic effects on acute promyelocytic leukaemia model (2018)

Torello, Cristiane Okuda; Shiraishi, Rodrigo Naoto; Della Via, Fernanda Isabel; Castro, Tamara Cristina Lopes de; Longhini, Ana Leda; Santos, Irene; Bombeiro, André Luis; Silva, Cleide Lúcia Araujo; Queiroz, Mary Luci de Souza; Rego, Eduardo Magalhães; Saad, Sara Teresinha Olalla

Source: Cancer Letters. Unidade: FMRP

Subjects: APOPTOSE, CÉLULAS DA MEDULA ÓSSEA, MODELOS ANIMAIS DE DOENÇAS, LEUCEMIA, FITOTERAPIA, ESPÉCIES REATIVAS DE OXIGÊNIO

USP Schools

ReP

Filtros

Authors

Subjects

Indexado em